Understanding heterogeneity in clinical and pre-clinical data

Immuneering helps pharmaceutical and biotech companies tackle challenging unanswered questions related to disease biology, therapeutic mechanism of action, differing responses in subsets of patients, and differing observations in studies conducted in vitro. Our proprietary approach yields compelling new hypotheses that contribute to the successful development of medicines for cancer, neurodegeneration, autoimmunity, and other diseases.